CompletedNot Applicable

Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer

United States103 participantsStarted 2009-12

Plain-language summary

RATIONALE: Collecting information about the impact of lymphedema on symptoms, functional status, and quality of life after treatment in patients with head and neck cancer may help doctors learn more about the disease and plan the best treatment. PURPOSE: This phase I trial is studying the effects of secondary lymphedema on symptoms, functional status, and quality of life after treatment in patients with head and neck cancer.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Diagnosed with head and neck cancer * At least 3 months since completion of head and neck cancer treatment * Participating in the Pain and Symptom Management Program at the Vanderbilt-Ingram Cancer Center * No current evidence of cancer * No metastatic disease PATIENT CHARACTERISTICS: * No other active cancer * Able to understand informed consent PRIOR CONCURRENT THERAPY: * See Disease Characteristics * No concurrent chemotherapy or radiotherapy

What they're measuring

Association between the severity of lymphedema with symptoms, functional status, and quality of life

Timeframe: Cross-sectional

Factors contributing to the development of secondary lymphedema

Timeframe: Cross-sectional Study

Trial details

NCT IDNCT01098669

SponsorVanderbilt University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-02

View on ClinicalTrials.gov More Cancer Survivor trials